[Monoclonal antibody analysis of human pancreatic juice components related to the pancreatic calculi protein].
A CaCO3-crystal growth inhibitor has recently been isolated from the calculi of patients affected by pancreatic lithiasis. It is a phosphoglycoprotein, with a molecular weight of 14,000, whose probable physiological role is the stabilization of exocrine pancreatic secretion which is supersaturated with respect to CaCO3. In order to isolate this inhibitor from human pancreatic juice, monoclonal antibodies to the protein were prepared and an immunoadsorbent column was developed. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis of proteins fixed by the immunoadsorbent reveals the form having a molecular weight of 14,000, in addition to other protein bands which have higher molecular weights (16,000, 16,800, 18,000, and 18,800). All of these different proteins are also recognized by a monospecific polyclonal antibody to the 14,000 molecular weight form. Using the same monospecific polyclonal antibody only one messenger RNA coding for this inhibitor has been demonstrated. Thus, this heterogeneity might be explained by post-translational modifications.
D000911:Antibodies, Monoclonal; D002119:Calcium Carbonate; D002135:Calcium-Binding Proteins / Q000302:isolation & purification*; D003460:Crystallization; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D007163:Immunosorbent Techniques; D051847:Lithostathine; D008970:Molecular Weight; D009419:Nerve Tissue Proteins; D010189:Pancreatic Juice / Q000032:analysis*
D000911:Antibodies, Monoclonal; D002135:Calcium-Binding Proteins; D051847:Lithostathine; D009419:Nerve Tissue Proteins; C497617:REG1A protein, human; D002119:Calcium Carbonate
Analyse au moyen d'un anticorps monoclonal des composants du suc pancréatique humain apparentés à la protéine des calculs pancréatiques.